| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Loss from a Novel Repressor Complex1 New York University Cancer Institute, New York, New York; 2 Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia; 3 Mount Sinai School of Medicine, New York, New York; and 4 Stadtische Kliniken, Offenbach, Germany
Requests for reprints: Anna C. Ferrari, New York University Cancer Institute, New York University School of Medicine, 8th Floor, 160 East 34th Street, New York, NY 10016. Phone: 212-731-5389; Fax: 212-731-5455; E-mail: anna.ferrari{at}nyumc.org.
Key Words: androgen receptor hormone refractory transcriptional repressor
Increased androgen receptor (AR) expression and activity are pivotal for androgen-independent (AI) prostate cancer (PC) progression and resistance to androgen-deprivation therapy. We show that a novel transcriptional repressor complex that binds a specific sequence (repressor element) in the AR gene 5'-untranslated region contains Pur
and hnRNP-K. Pur
expression, its nuclear localization, and its AR promoter association, as determined by chromatin immunoprecipitation analysis, were found to be significantly diminished in AI-LNCaP cells and in hormone-refractory human PCs. Transfection of AI cells with a plasmid that restored Pur
expression reduced AR at the transcription and protein levels. Pur
knockdown in androgen-dependent cells yielded higher AR and reduced p21, a gene previously shown to be under negative control of AR. These changes were linked to increased proliferation in androgen-depleted conditions. Treatment of AI cells with histone deacetylase and DNA methylation inhibitors restored Pur
protein and binding to the AR repressor element. This correlated with decreased AR mRNA and protein levels and inhibition of cell growth. Pur
is therefore a key repressor of AR transcription and its loss from the transcriptional repressor complex is a determinant of AR overexpression and AI progression of PC. The success in restoring Pur
and the repressor complex function by pharmacologic intervention opens a promising new therapeutic approach for advanced PC. [Cancer Res 2008;68(8):2678–88]
This article has been cited by other articles:
![]() |
C. Cai, D. C. Portnoy, H. Wang, X. Jiang, S. Chen, and S. P. Balk Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2 Cancer Res., June 15, 2009; 69(12): 5202 - 5209. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, L. Wang, M. Zhang, J. Melamed, X. Liu, R. Reiter, J. Wei, Y. Peng, X. Zou, A. Pellicer, et al. LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion Cancer Res., April 15, 2009; 69(8): 3332 - 3338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Mukhopadhyay, J. Kim, B. Cinar, A. Ramachandran, M. H. Hager, D. Di Vizio, R. M. Adam, M. A. Rubin, P. Raychaudhuri, A. De Benedetti, et al. Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation Cancer Res., March 15, 2009; 69(6): 2210 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, S. Ko, S. Kim, I. Echchgadda, T.-S. Oh, C. S. Song, and B. Chatterjee Loss of Androgen Receptor in Aging and Oxidative Stress through Myb Protooncoprotein-regulated Reciprocal Chromatin Dynamics of p53 and Poly(ADP-ribose) Polymerase PARP-1 J. Biol. Chem., December 26, 2008; 283(52): 36474 - 36485. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |